Notably, at a global level, MAF expression was significantly reduced in ECs from donors with cirrhosis (Fig. 8D), while it was preserved in the few LSECs that retained a pericentral, midzonal, or periportal expression profile (Fig. 8E). Here, MAF is linked to Cirrhosis.